Form D · Other Health Care

GID BIO, Inc.

Louisville, CO · CIK 0001490638

Offering snapshot reported Jan 4, 2022 · SEC filing

Reported sold
$5.34M
Indefinite offering
Investors reported
27
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Dec 22, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 4, 2022Initial$5,335,340No comparison27SEC filing
Jan 10, 2014Initial$2,162,622No comparison18SEC filing
Dec 1, 2011Initial$2,664,272No comparison23SEC filing
May 20, 2010Initial$2,499,936No comparison22SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-427803

Source: Form D, filed Jan 4, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Roy Bostock Director
William W Ciminio Director, Executive
William Cimino Director, Executive
Ruben Diaz Director
J. William Futrell Director, Executive
J William Futrell Director, Executive
William Futrell Director
Adam Katz Director
John Marous Director
Nicholas Pachuda Director
Carlos Pellas Director
Jesse Shefferman Director
David S. Smith Executive
Morgan St. John Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
901 Front Street, Suite 240
Louisville, CO, 80027